Earnings Release • Apr 22, 2013
Earnings Release
Open in ViewerOpens in native device viewer
"We made solid progress again in the first quarter as all sectors contributed to the 31% improvement of our operational results, clearly demonstrating the positive impact our Accelerate! transformation program is having on our company. The initiatives to improve gross margins, structurally lower our cost base and reduce our inventory levels led to a better performance in the quarter. Consumer Lifestyle sales did very well, with strong 10% growth, as our locally relevant products and granular approach to drive growth delivered results. At Lighting, LED-based sales grew 38% over the previous year. Weak construction markets negatively impacted overall Lighting sales which were flat compared to the first quarter of 2012. At Healthcare, lower order intake in 2012 impacted sales, mainly in the US.
We reiterate our view of a slow first half to 2013, due to adverse market trends, especially in Europe and the US. We will continue to drive the execution of the Accelerate! initiatives, which include major productivity improvements and investments in innovation and sales capabilities, as we are convinced that our strong focus on operational excellence and organic growth will further unlock the full potential of Philips. We are committed to reach our financial targets this year."
Healthcare comparable sales declined by 1% year-on-year. Customer Services and Home Healthcare Solutions had lowsingle-digit growth, Patient Care & Clinical Informatics sales were flat, and Imaging Systems sales had a high-single-digit decline. Currency-comparable equipment order intake declined by 5%. EBITA margin improved to 10.4% of sales. EBITA margin excluding restructuring and other charges was 10.5% of sales, a year-on-year improvement of 0.9 percentage points.
Consumer Lifestyle comparable sales were 10% higher year-on-year, driven by double-digit growth at Domestic Appliances, high-single-digit growth at Personal Care, and mid-single-digit growth at Health & Wellness. EBITA margin was 9.8%. EBITA margin excluding restructuring and other charges was 9.9% of sales, a year-on-year improvement of 3.2 percentage points.
Lighting comparable sales were in line with Q1 2012 as double-digit growth at Lumileds and mid-single-digit growth at Automotive were offset by declines in the other businesses. LED-based sales grew 38% compared to Q1 2012 and now represent 23% of Lighting sales. EBITA margin improved to 7.4%. EBITA margin excluding restructuring and other charges was 8.4%, an improvement of 3.7 percentage points.
Philips has completed 86% of the EUR 2 billion share buy-back program since the start of the program in July 2011.
Prior-period financials have been revised for the adoption of IAS19R, which mainly relates to pension reporting.
Our multi-year change and performance improvement program, Accelerate!, is now nearing its 2nd anniversary and has delivered solid results. The Accelerate! program will run through 2017 and has five comprehensive streams to enhance customer relevance, change the company culture, reduce overhead costs, streamline our end-to-end customer value chains, and re-allocate resources to profitable growth opportunities.
To support this transformation, over 900 senior leaders have participated in change management programs to create a high-performance culture. Our quarterly surveys conducted across 40,000 employees confirm that our Accelerate! initiatives are impacting all levels of the organization. We have launched our DfX program (DfX stands for Design for X, where X can be cost, quality, manufacturing, etc.) to reduce our bill of materials and improve value creation. The first pilots of our DfX program have clearly demonstrated the potential for improvement in this area. We have simplified the value chain in executed projects, which has led to an improvement of around 25% in customer service levels in Q1 2013 and reduced time-to-market of new innovations. Our overhead cost reduction program has resulted in EUR 549 million cumulative gross savings to date, including EUR 78 million realized in Q1 2013. We reduced inventory levels by 1.4 percentage points year-on-year this quarter.
Please refer to page 16 of this press release for more information about forward-looking statements, third-party market share data, use of non-GAAP information and use of fair-value measurements.
in millions of euros unless otherwise stated
| Q1 | Q1 | |
|---|---|---|
| 2012 | 2013 | |
| Sales | 5,307 | 5,258 |
| EBITA | 451 | 402 |
| as a % of sales | 8.5 | 7.6 |
| EBIT | 341 | 305 |
| as a % of sales | 6.4 | 5.8 |
| Financial income (expenses) | (75) | (83) |
| Income taxes | (62) | (69) |
| Results investments in associates | (3) | 1 |
| Net income from continuing operations | 201 | 154 |
| Discontinued operations | (18) | 8 |
| Net income | 183 | 162 |
| Net income - shareholders per common share (in euros) - basic |
0.20 | 0.18 |
in millions of euros unless otherwise stated
| Q1 | Q1 | % change | ||
|---|---|---|---|---|
| 2012 | 2013 | nominal comparable | ||
| Healthcare | 2,209 | 2,127 | (4) | (1) |
| Consumer Lifestyle | 923 | 1,003 | 9 | 10 |
| Lighting | 2,015 | 1,975 | (2) | 0 |
| Innovation, Group & | ||||
| Services | 160 | 153 | (4) | (4) |
| Philips Group | 5,307 | 5,258 | (1) | 1 |
in millions of euros unless otherwise stated
| Q1 | Q1 | % change | ||
|---|---|---|---|---|
| 2012 | 2013 | nominal comparable | ||
| Western Europe | 1,365 | 1,341 | (2) | (2) |
| North America | 1,722 | 1,650 | (4) | (3) |
| Other mature geographies | 483 | 493 | 2 | 10 |
| Total mature geographies | 3,570 | 3,484 | (2) | (1) |
| Growth geographies | 1,737 | 1,774 | 2 | 4 |
| Philips Group | 5,307 | 5,258 | (1) | 1 |
in millions of euros
| Q1 | Q1 | |
|---|---|---|
| 2012 | 2013 | |
| Healthcare | 202 | 222 |
| Consumer Lifestyle | 211 | 98 |
| Lighting | 46 | 147 |
| Innovation, Group & Services | (8) | (65) |
| Philips Group | 451 | 402 |
as a % of sales
| Q1 | Q1 | |
|---|---|---|
| 2012 | 2013 | |
| Healthcare | 9.1 | 10.4 |
| Consumer Lifestyle | 22.9 | 9.8 |
| Lighting | 2.3 | 7.4 |
| Innovation, Group & Services | (5.0) | (42.5) |
| Philips Group | 8.5 | 7.6 |
in millions of euros
| Q1 | Q1 | |
|---|---|---|
| 2012 | 2013 | |
| Healthcare | (9) | (2) |
| Consumer Lifestyle | (11) | (1) |
| Lighting | (24) | (19) |
| Innovation, Group & Services | 1 | 3 |
| Philips Group | (43) | (19) |
in millions of euros unless otherwise stated
| Q1 | Q1 | |
|---|---|---|
| 2012 | 2013 | |
| Healthcare | 151 | 176 |
| Consumer Lifestyle | 197 | 84 |
| Lighting | 2 | 110 |
| Innovation, Group & Services | (9) | (65) |
| Philips Group | 341 | 305 |
| as a % of sales | 6.4 | 5.8 |
| in millions of euros | ||
|---|---|---|
| Q1 | Q1 | |
| 2012 | 2013 | |
| Net interest expenses | (74) | (74) |
| Value adjustment to option in the UK pension plan |
19 | 2 |
| Other | (20) | (11) |
| (75) | (83) |
in millions of euros
| Q1 | Q1 | |
|---|---|---|
| 2012 | 2013 | |
| Beginning cash balance | 3,147 | 3,834 |
| Free cash flow | 626 | (431) |
| Net cash flow from operating activities | 297 | (228) |
| Net capital expenditures | 329 | (203) |
| Acquisitions of businesses | (230) | (11) |
| Other cash flow from investing activities | (176) | (70) |
| Treasury shares transactions | (154) | (222) |
| Changes in debt/other | 1,116 | 16 |
| Net cash flow discontinued operations | (104) | (50) |
| Ending balance | 4,225 | 3,066 |
in millions of euros
• Financial income and expenses amounted to a net expense of EUR 83 million. This is EUR 8 million higher than Q1 2012, which included a EUR 19 million gain on value adjustment related to the option in the UK pension plan. Net interest expense was in line with Q1 2012.
• Cash flow from operating activities for the quarter was an outflow of EUR 228 million, compared to an inflow of EUR 297 million in Q1 2012. Q1 2013 was impacted by the payment of the EUR 509 million European Commission fine, while Q1 2012 included cash inflows of EUR 543 million from the Senseo transaction and the sale of the High Tech Campus real estate. Excluding these one-off cash flows, the cash flow from operating activities in Q1 2013 improved to an inflow of EUR 281 million, compared to a cash outflow of EUR 246 million in Q1 2012.
in millions of euros
as a % of moving annual total sales
Gross capital expenditure
equipment were EUR 13 million lower than in Q1 2012, mainly due to lower investments at Healthcare and Lighting.
• Gross capital expenditures on property, plant and
• Compared to Q1 2012, inventories were 1.4 percentage points of sales lower. This was attributable to all sectors, but mainly driven by inventory productivity improvements at Healthcare.
1) Capital expenditures on property, plant and equipment only
2) Excludes discontinued operations for both inventories and sales figures. Inventories excluding discontinued operations are disclosed in quarterly statistics.
1) Number of employees excludes discontinued operations, comprising the Audio, Video, Multimedia and Accessories business, which employed 1,970 FTEs at the end of Q1 2013 , 2,005 FTEs at the end of Q4 2012 , and 2,285 FTEs at the end of Q1 2012
in millions of euros unless otherwise stated
| Q1 | Q1 | |
|---|---|---|
| 2012 | 2013 | |
| Sales | 2,209 | 2,127 |
| Sales growth | ||
| % nominal | 12 | (4) |
| % comparable | 9 | (1) |
| EBITA | 202 | 222 |
| as a % of sales | 9.1 | 10.4 |
| EBIT | 151 | 176 |
| as a % of sales | 6.8 | 8.3 |
| Net operating capital (NOC) | 8,039 | 7,888 |
| Number of employees (FTEs) | 37,951 | 37,270 |
in millions of euros
EBITA
• Currency-comparable equipment orderintake declined 5% year-on-year. Order intake at Patient Care & Clinical Informatics and Imaging Systems declined in the quarter. Equipment orders in Europe showed a highsingle-digit decline due to weak markets in Western Europe. Orders in North America showed a doubledigit decline, reflecting the continued market uncertainties. Equipment orders in growth geographies declined by 4%.
• Restructuring and acquisition-related charges in Q2 2013 are expected to total approximately EUR 5 million.
* Excluding the Audio, Video, Multimedia and Accessories business
in millions of euros unless otherwise stated
| Q1 | Q1 | |
|---|---|---|
| 2012 | 2013 | |
| Sales | 923 | 1,003 |
| Sales growth | ||
| % nominal | 12 | 9 |
| % comparable | 7 | 10 |
| EBITA | 211 | 98 |
| as a % of sales | 22.9 | 9.8 |
| EBIT | 197 | 84 |
| as a % of sales | 21.3 | 8.4 |
| Net operating capital (NOC) | 1,215 | 1,092 |
| Number of employees (FTEs) | 15,949 | 16,891 |
Sales
in millions of euros
EBITA
EBITA amounted to EUR 98 million, compared to EUR 211 million in Q1 2012, which included a EUR 160 million gain on the Senseo transaction. EBITA in Q1 2013 included restructuring and acquisition-related charges of EUR 1 million (Q1 2012: EUR 11 million) and EUR 7 million of net costs formerly reported as part of the Audio, Video, Multimedia and Accessories business in Consumer Lifestyle (Q1 2012 included EUR 8 million related to the Audio, Video, Multimedia and Accessories business and EUR 14 million related to the Television business).
Excluding restructuring and acquisition-related charges and the Q1 2012 gain on the Senseo transaction, EBITA increased by EUR 37 million to EUR 99 million, or 9.9% ofsales, compared to EUR 62 million, or 6.7% ofsales, in Q1 2012. The EBITA improvement was driven by higher gross margin across all businesses and the elimination of stranded costs related to the Television business.
• Restructuring and acquisition-related charges in Q2 2013 are expected to total approximately EUR 5 million.
in millions of euros unless otherwise stated
| Q1 | Q1 | |
|---|---|---|
| 2012 | 2013 | |
| Sales | 2,015 | 1,975 |
| Sales growth | ||
| % nominal | 6 | (2) |
| % comparable | 2 | 0 |
| EBITA | 46 | 147 |
| as a % of sales | 2.3 | 7.4 |
| EBIT | 2 | 110 |
| as a % of sales | 0.1 | 5.6 |
| Net operating capital (NOC) | 5,004 | 4,664 |
| Number of employees (FTEs) | 53,169 | 49,404 |
in millions of euros
EBITA
EBITA amounted to EUR 147 million, compared to EUR 46 million in 2012, and included restructuring and acquisition-related charges of EUR 19 million (Q1 2012: EUR 24 million). In Q1 2012, EBITA was also impacted by a EUR 25 million loss on the sale of industrial assets.
Excluding restructuring and acquisition-related charges and the loss on the sale of industrial assets in Q1 2012, EBITA was EUR 166 million, or 8.4% of sales, compared to EUR 95 million, or 4.7% of sales, in Q1 2012. The improvement was driven by a lower bill of materials, including lower phosphor prices as well as overhead cost savings.
• Restructuring and acquisition-related charges in Q2 2013 are expected to total approximately EUR 30 million.
in millions of euros unless otherwise stated
| Q1 | Q1 | |
|---|---|---|
| 2012 | 2013 | |
| Sales | 160 | 153 |
| Sales growth | ||
| % nominal | (22) | (4) |
| % comparable | (9) | (4) |
| EBITA of: | ||
| Group Innovation | (36) | (30) |
| IP Royalties | 59 | 52 |
| Group and Regional Costs | (33) | (36) |
| Accelerate! investments | (26) | (29) |
| Pensions | (2) | (4) |
| Service Units and Other | 30 | (18) |
| EBITA | (8) | (65) |
| EBIT | (9) | (65) |
| Net operating capital (NOC) | (3,624) | (3,675) |
| Number of employees (FTEs) | 12,654 | 12,346 |
in millions of euros
EBITA
in millions of euros
• Restructuring and acquisition-related charges in Q2 2013 are expected to total approximately EUR 15 million.
| 2012 | 2013 | |
|---|---|---|
| 1st quarter | 1st quarter | |
| AVM&A EBITA | 16 | (1) |
| Disentanglement costs | − | (8) |
| Former AVM&A net costs allocated to Consumer Lifestyle |
8 | 7 |
| Former AVM&A net costs allocated to IG&S |
10 | 18 |
| Eliminated amortization other AVM&A intangibles |
(4) | − |
| EBIT discontinued operations | 30 | 16 |
| Income taxes | (12) | (6) |
| Investment in associates | (3) | − |
| Net income of discontinued operations | 15 | 10 |
| Number of employees (FTEs) | 2,285 | 1,970 |
This document and the related oral presentation, including responses to questions following the presentation, contain certain forward-looking statements with respect to the financial condition, results of operations and business of Philips and certain of the plans and objectives of Philips with respect to these items. Examples of forward-looking statements include statements made about our strategy, estimates of sales growth, future EBITA and future developments in our organic business. By their nature, these statements involve risk and uncertainty because they relate to future events and circumstances and there are many factors that could cause actual results and developments to differ materially from those expressed or implied by these statements.
These factors include but are not limited to domestic and global economic and business conditions, developments within the euro zone, the successful implementation of our strategy and our ability to realize the benefits of this strategy, our ability to develop and market new products, changes in legislation, legal claims, changes in exchange and interest rates, changes in tax rates, pension costs and actuarial assumptions, raw materials and employee costs, our ability to identify and complete successful acquisitions and to integrate those acquisitions into our business, our ability to successfully exit certain businesses or restructure our operations, the rate of technological changes, political, economic and other developments in countries where Philips operates, industry consolidation and competition. As a result, Philips' actual future results may differ materially from the plans, goals and expectations set forth in such forward-looking statements. For a discussion of factors that could cause future results to differ from such forward-looking statements, see the Risk management chapter included in our Annual Report 2012.
Statements regarding market share, including those regarding Philips' competitive position, contained in this document are based on outside sources such as research institutes, industry and dealer panels in combination with management estimates. Where information is not yet available to Philips, those statements may also be based on estimates and projections prepared by outside sources or management. Rankings are based on sales unless otherwise stated.
In presenting and discussing the Philips Group's financial position, operating results and cash flows, management uses certain non-GAAP financial measures. These non-GAAP financial measures should not be viewed in isolation as alternatives to the equivalent IFRS measures and should be used in conjunction with the most directly comparable IFRS measures. A reconciliation of such measures to the most directly comparable IFRS measures is contained in this document. Further information on non-GAAP measures can be found in our Annual Report 2012.
In presenting the Philips Group's financial position, fair values are used for the measurement of various items in accordance with the applicable accounting standards. These fair values are based on market prices, where available, and are obtained from sources that are deemed to be reliable. Readers are cautioned that these values are subject to changes over time and are only valid at the balance sheet date. When quoted prices do not exist, we estimated the fair values using appropriate valuation models, and when observable market data are not available, we used unobservable inputs. They require management to make significant assumptions with respect to future developments, which are inherently uncertain and may therefore deviate from actual developments. Critical assumptions used are disclosed in our 2012 financial statements. Independent valuations may have been obtained to support management's determination of fair values.
All amounts in millions of euros unless otherwise stated; data included are unaudited. Financial reporting is in accordance with the accounting policies as stated in the Annual Report 2012, unless otherwise stated.
Prior-period financials have been revised for the treatment of Audio, Video, Multimedia and Accessories as discontinued operations, the adoption of IAS19R, which mainly relates to pension reporting, and adjustments to the quarterly figures of 2012, which have already been included in the Annual Report 2012 (for an explanation we refer to Annual Report section 12.10 "Significant Accounting Policies").
An overview of the revised 2012 figures per quarter will become available on the Philips website, in the Investor Relations section.
in millions of euros unless otherwise stated
| January to March | ||
|---|---|---|
| 2012 | 2013 | |
| Sales | 5,307 | 5,258 |
| Cost of sales | (3,299) | (3,157) |
| Gross margin | 2,008 | 2,101 |
| Selling expenses | (1,196) | (1,190) |
| General and administrative expenses | (199) | (200) |
| Research and development expenses | (450) | (424) |
| Other business income | 215 | 26 |
| Other business expenses | (37) | (8) |
| Income from operations | 341 | 305 |
| Financial income | 37 | 18 |
| Financial expenses | (112) | (101) |
| Income before taxes | 266 | 222 |
| Income tax expense | (62) | (69) |
| Income after taxes | 204 | 153 |
| Results relating to investments in associates | (3) | 1 |
| Net income from continuing operations | 201 | 154 |
| Discontinued operations - net of income tax | (18) | 8 |
| Net income | 183 | 162 |
| Attribution of net income for the period | ||
| Net income attributable to shareholders | 182 | 161 |
| Net income attributable to non-controlling interests | 1 | 1 |
| Weighted average number of common shares outstanding (after deduction of treasury shares) during the period (in thousands): |
||
| - basic | 923,8291) | 909,450 |
| - diluted | 927,8411) | 920,351 |
| Net income attributable to shareholders per common share in euros: | ||
| - basic | 0.20 | 0.18 |
| - diluted | 0.20 | 0.17 |
| Ratios | ||
| Gross margin as a % of sales | 37.8 | 40.0 |
| Selling expenses as a % of sales | (22.5) | (22.6) |
| G&A expenses as a % of sales | (3.7) | (3.8) |
| R&D expenses as a % of sales | (8.5) | (8.1) |
| EBIT as a % of sales |
341 6.4 |
305 5.8 |
| EBITA | 451 | 402 |
| as a % of sales | 8.5 | 7.6 |
1) Adjusted to make 2012 comparable for the bonus shares (889 thousand) issued in May 2012
in millions of euros unless otherwise stated
| April 1, | December 31, | March 31, | |
|---|---|---|---|
| 2012 | 2012 | 2013 | |
| Non-current assets: | |||
| Property, plant and equipment | 2,947 | 2,959 | 2,971 |
| Goodwill | 6,856 | 6,948 | 7,028 |
| Intangible assets excluding goodwill | 3,942 | 3,731 | 3,698 |
| Non-current receivables | 127 | 176 | 190 |
| Investments in associates | 199 | 177 | 176 |
| Other non-current financial assets | 579 | 549 | 571 |
| Deferred tax assets | 1,738 | 1,919 | 1,931 |
| Other non-current assets | 66 | 94 | 78 |
| Total non-current assets | 16,454 | 16,553 | 16,643 |
| Current assets: | |||
| Inventories - net | 3,819 | 3,495 | 3,631 |
| Other current financial assets | − | − | 1 |
| Other current assets | 411 | 337 | 431 |
| Derivative financial assets | 129 | 137 | 142 |
| Income tax receivable | 155 | 97 | 87 |
| Receivables | 4,714 | 4,585 | 4,278 |
| Assets classified as held for sale | 80 | 43 | 447 |
| Cash and cash equivalents | 4,225 | 3,834 | 3,066 |
| Total current assets | 13,533 | 12,528 | 12,083 |
| Total assets | 29,987 | 29,081 | 28,726 |
| Shareholders' equity | 12,227 | 11,151 | 11,160 |
| Non-controlling interests | 33 | 34 | 37 |
| Group equity | 12,260 | 11,185 | 11,197 |
| Non-current liabilities: Long-term debt |
3,975 | 3,725 | 3,560 |
| Long-term provisions | 1,902 | 2,119 | 2,074 |
| Deferred tax liabilities | 131 | 92 | 79 |
| Other non-current liabilities | 1,938 | 2,005 | 1,983 |
| Total non-current liabilities | 7,946 | 7,941 | 7,696 |
| Current liabilities: | |||
| Short-term debt | 1,037 | 809 | 1,042 |
| Derivative financial liabilities | 528 | 517 | 569 |
| Income tax payable | 174 | 200 | 165 |
| Accounts and notes payable | 3,327 | 2,839 | 2,904 |
| Accrued liabilities | 2,896 | 3,171 | 2,935 |
| Short-term provisions | 638 | 837 | 751 |
| Liabilities directly associated with assets held for sale | 52 | 27 | 283 |
| Other current liabilities | 1,129 | 1,555 | 1,184 |
| Total current liabilities | 9,781 | 9,955 | 9,833 |
| Total liabilities and group equity | 29,987 | 29,081 | 28,726 |
| April 1, | December 31, | March 31, | |
|---|---|---|---|
| 2012 | 2012 | 2013 | |
| Number of common shares outstanding (after deduction of treasury shares) at the end of period (in thousands) |
915,926 | 914,591 | 905,381 |
| Ratios | |||
| Shareholders' equity per common share in euros | 13.35 | 12.19 | 12.33 |
| Inventories as a % of sales | 16.9 | 14.3 | 15.5 |
| Net debt : group equity | 6:94 | 6:94 | 12:88 |
| Net operating capital | 10,634 | 9,316 | 9,969 |
| Employees at end of period | 122,008 | 118,087 | 117,881 |
| of which discontinued operations | 2,285 | 2,005 | 1,970 |
in millions of euros
| January to March | ||
|---|---|---|
| 2012 | 2013 | |
| Cash flows from operating activities: | ||
| Net income | 183 | 162 |
| Loss from discontinued operations | 18 | (8) |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||
| Depreciation and amortization | 336 | 305 |
| Impairment of goodwill and other non-current financial assets | − | 1 |
| Net gain on sale of assets | (184) | (4) |
| Income from investments in associates | − | (2) |
| Increase in working capital: | (54) | (463) |
| Decrease in receivables and other current assets | 250 | 135 |
| Increase in inventories | (221) | (205) |
| Decrease in accounts payable, accrued and other liabilities | (83) | (393) |
| Increase in non-current receivables, other assets and other liabilities | (85) | (77) |
| Increase (decrease) in provisions | 27 | (98) |
| Other items | 56 | (44) |
| Net cash provided by (used for) operating activities | 297 | (228) |
| Cash flows from investing activities: | ||
| Purchase of intangible assets | (6) | (2) |
| Proceeds from sale of intangible assets | 160 | − |
| Expenditures on development assets | (76) | (80) |
| Capital expenditures on property, plant and equipment | (137) | (124) |
| Proceeds from disposals of property, plant and equipment | 388 | 3 |
| Cash to derivatives and securities | (24) | (72) |
| Purchase of other non-current financial assets | (152) | − |
| Proceeds from other non-current financial assets | − | 2 |
| Purchase of businesses, net of cash acquired | (241) | (10) |
| Proceeds from sale of interests in businesses, net of cash disposed of | 11 | (1) |
| Net cash used for investing activities | (77) | (284) |
| Cash flows from financing activities: | ||
| Proceeds from (to) issuance of short-term debt | 41 | (19) |
| Principal payments on long-term debt | (24) | (22) |
| Proceeds from issuance of long-term debt | 1,137 | 17 |
| Treasury shares transactions | (154) | (222) |
| Net cash provided by (used for) financing activities | 1,000 | (246) |
| Net cash provided by (used for) continuing operations | 1,220 | (758) |
| Cash flow from discontinued operations: Net cash provided by (used for) operating activities |
44 | (50) |
| Net cash used for investing activities | (148) | − |
| Net cash used for discontinued operations | (104) | (50) |
| Net cash provided by (used for) continuing and discontinued operations | 1,116 | (808) |
| Effect of change in exchange rates on cash and cash equivalents | (38) | 40 |
| Cash and cash equivalents at the beginning of the period | 3,147 | 3,834 |
| Cash and cash equivalents at the end of the period | 4,225 | 3,066 |
| January to March | ||
|---|---|---|
| 2012 | 2013 | |
| Ratio | ||
| Cash flows before financing activities | 220 | (512) |
| Net cash paid during the period for | ||
| Pensions | (194) | (198) |
| Interest | (76) | (93) |
| Income taxes | (81) | (143) |
For a number of reasons, principally the effects of translation differences, certain items in the statements of cash flows do not correspond to the differences between the balance sheet amounts for the respective items.
in millions of euros
| other reserves | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| com mon shares |
capital in ex cess of par val ue |
re tained earn ings |
revalua tion re serve |
curren cy transla tion dif feren ces |
unreal ized gain (loss) on avail able for-sale financial assets |
changes in fair value of cash flow hedges |
total | treas ury shares at cost |
total share holders' equity |
non con trolling inter ests |
total equity |
|
| January to March 2013 | ||||||||||||
| Balance as of December 31, 2012 |
191 | 1,304 | 10,724 | 54 | (93) | 54 | 20 | (19) | (1,103) | 11,151 | 34 | 11,185 |
| Net income | 161 | 161 | 1 | 162 | ||||||||
| Net current-period change | (7) | (4) | 48 | 7 | 7 | 62 | 51 | 51 | ||||
| Reclassifications into income | − | 1 | (6) | (5) | (5) | (5) | ||||||
| Total comprehensive income | 154 | (4) | 48 | 8 | 1 | 57 | 207 | 1 | 208 | |||
| Movement non-controlling interest |
− | − | 2 | 2 | ||||||||
| Purchase of treasury shares | − | (258) | (258) | (258) | ||||||||
| Re-issuance of treasury shares | (5) | (26) | 64 | 33 | 33 | |||||||
| Share-based compensation plans | 23 | 23 | 23 | |||||||||
| Income tax share-based compensation plans |
4 | 4 | 4 | |||||||||
| − | 22 | (26) | (194) | (198) | 2 | (196) | ||||||
| Balance as of March 31, 2013 |
191 | 1,326 | 10,852 | 50 | (45) | 62 | 21 | 38 | (1,297) | 11,160 | 37 | 11,197 |
in millions of euros unless otherwise stated
| January to March | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2012 | 2013 | ||||||||
| sales | income from operations | income from operations | |||||||
| amount | as a % of sales | amount | as a % of sales | ||||||
| Healthcare | 2,209 | 151 | 6.8 | 2,127 | 176 | 8.3 | |||
| Consumer Lifestyle | 923 | 197 | 21.3 | 1,003 | 84 | 8.4 | |||
| Lighting | 2,015 | 2 | 0.1 | 1,975 | 110 | 5.6 | |||
| Innovation, Group & Services | 160 | (9) | − | 153 | (65) | − | |||
| 5,307 | 341 | 6.4 | 5,258 | 305 | 5.8 |
in millions of euros
| sales | total assets | |||
|---|---|---|---|---|
| January to March | April 1, | March 31, | ||
| 2012 | 2013 | 2012 | 2013 | |
| Healthcare | 2,209 | 2,127 | 11,264 | 11,371 |
| Consumer Lifestyle | 923 | 1,003 | 3,787 | 2,837 |
| Lighting | 2,015 | 1,975 | 7,002 | 7,163 |
| Innovation, Group & Services | 160 | 153 | 7,855 | 6,908 |
| 5,307 | 5,258 | 29,907 | 28,279 | |
| Assets classified as held for sale | 80 | 447 | ||
| 29,987 | 28,726 |
| sales | tangible and intangible assets1) | ||||
|---|---|---|---|---|---|
| January to March | April 1, | March 31, | |||
| 2012 | 2013 | 2012 | 2013 | ||
| Netherlands | 146 | 146 | 841 | 874 | |
| United States | 1,581 | 1,506 | 8,209 | 8,135 | |
| China | 565 | 607 | 1,092 | 1,141 | |
| Germany | 303 | 310 | 249 | 274 | |
| Japan | 305 | 307 | 562 | 495 | |
| France | 222 | 213 | 96 | 88 | |
| United Kingdom | 164 | 170 | 618 | 578 | |
| Other countries | 2,021 | 1,999 | 2,078 | 2,112 | |
| 5,307 | 5,258 | 13,745 | 13,697 |
1) Includes property, plant and equipment, intangible assets excluding goodwill, and goodwill
in millions of euros
| 2012 | 2013 | ||||
|---|---|---|---|---|---|
| Netherlands | other | total | Netherlands | other | total |
| 44 | 22 | 66 | 48 | 20 | 68 |
| − | 19 | 19 | − | 16 | 16 |
| (1) | − | (1) | (1) | − | (1) |
| 43 | 41 | 84 | 47 | 36 | 83 |
| − | 1 | 1 | 1 | − | 1 |
| − | 1 | 1 | − | 1 | 1 |
| − | 3 | 3 | − | 3 | 3 |
| − | 4 | 4 | − | 4 | 4 |
| 3 | 37 | 40 | 2 | 40 | 42 |
| 1 | 1 | 2 | − | − | − |
| January to March |
in millions of euros unless otherwise stated
Certain non-GAAP financial measures are presented when discussing the Philips Group's performance. In the following tables, a reconciliation to the most directly comparable IFRS performance measure is made.
| January to March | |||||||
|---|---|---|---|---|---|---|---|
| comparable growth | currency effects | consolidation changes | nominal growth | ||||
| 2013 versus 2012 | |||||||
| Healthcare | (1.3) | (2.4) | − | (3.7) | |||
| Consumer Lifestyle | 9.8 | (1.1) | − | 8.7 | |||
| Lighting | (0.5) | (1.4) | (0.1) | (2.0) | |||
| Innovation, Group & Services | (4.0) | (0.4) | − | (4.4) | |||
| Philips Group | 0.9 | (1.8) | − | (0.9) |
| Philips Group | Healthcare | Consumer Lifestyle |
Lighting | IG&S | |
|---|---|---|---|---|---|
| January to March 2013 | |||||
| EBITA (or Adjusted income from operations) | 402 | 222 | 98 | 147 | (65) |
| Amortization of intangibles1) | (97) | (46) | (14) | (37) | − |
| Income from operations (or EBIT) | 305 | 176 | 84 | 110 | (65) |
| January to March 2012 | |||||
| EBITA (or Adjusted income from operations) | 451 | 202 | 211 | 46 | (8) |
| Amortization of intangibles1) | (110) | (51) | (14) | (44) | (1) |
| Income from operations (or EBIT) | 341 | 151 | 197 | 2 | (9) |
1) Excluding amortization of software and product development
| April 1, | March 31, | |
|---|---|---|
| 2012 | 2013 | |
| Long-term debt | 3,975 | 3,560 |
| Short-term debt | 1,037 | 1,042 |
| Total debt | 5,012 | 4,602 |
| Cash and cash equivalents | 4,225 | 3,066 |
| Net debt (cash) (total debt less cash and cash equivalents) | 787 | 1,536 |
| Shareholders' equity | 12,227 | 11,160 |
| Non-controlling interests | 33 | 37 |
| Group equity | 12,260 | 11,197 |
| Net debt and group equity | 13,047 | 12,733 |
| Net debt divided by net debt and group equity (in %) | 6 | 12 |
| Group equity divided by net debt and group equity (in %) | 94 | 88 |
in millions of euros
| Philips Group | Healthcare | Consumer Lifestyle |
Lighting | IG&S | |
|---|---|---|---|---|---|
| March 31, 2013 | |||||
| Net operating capital (NOC) | 9,969 | 7,888 | 1,092 | 4,664 | (3,675) |
| Exclude liabilities comprised in NOC: | |||||
| - payables/liabilities |
9,740 | 2,916 | 1,424 | 1,780 | 3,620 |
| - intercompany accounts |
− | 149 | 79 | 144 | (372) |
| - provisions |
2,825 | 330 | 242 | 554 | 1,699 |
| Include assets not comprised in NOC: | |||||
| - investments in associates |
176 | 88 | − | 21 | 67 |
| - other current financial assets |
1 | − | − | − | 1 |
| - other non-current financial assets |
571 | − | − | − | 571 |
| - deferred tax assets |
1,931 | − | − | − | 1,931 |
| - cash and cash equivalents |
3,066 | − | − | − | 3,066 |
| 28,279 | 11,371 | 2,837 | 7,163 | 6,908 | |
| Assets classified as held for sale | 447 | ||||
| Total assets | 28,726 | ||||
| April 1, 2012 | |||||
| Net operating capital (NOC) | 10,634 | 8,039 | 1,215 | 5,004 | (3,624) |
| Exclude liabilities comprised in NOC: | |||||
| - payables/liabilities |
9,992 | 2,761 | 2,160 | 1,587 | 3,484 |
| - intercompany accounts |
− | 83 | 40 | 87 | (210) |
| - provisions |
2,540 | 294 | 372 | 300 | 1,574 |
| Include assets not comprised in NOC: | |||||
| - investments in associates |
199 | 87 | − | 24 | 88 |
| - other non-current financial assets |
579 | − | − | − | 579 |
| - deferred tax assets |
1,738 | − | − | − | 1,738 |
| - cash and cash equivalents |
4,225 | − | − | − | 4,225 |
| 29,907 | 11,264 | 3,787 | 7,002 | 7,854 | |
| Assets classified as held for sale | 80 | ||||
| Total assets | 29,987 |
in millions of euros
| January to March | ||
|---|---|---|
| 2012 | 2013 | |
| Cash flows provided by (used for) operating activities | 297 | (228) |
| Cash flows used for investing activities | (77) | (284) |
| Cash flows before financing activities | 220 | (512) |
| Cash flows provided by (used for) operating activities | 297 | (228) |
| Net capital expenditures: | 329 | (203) |
| Purchase of intangible assets | (6) | (2) |
| Proceeds from sale of intangible assets | 160 | − |
| Expenditures on development assets | (76) | (80) |
| Capital expenditures on property, plant and equipment | (137) | (124) |
| Proceeds from sale of property, plant and equipment | 388 | 3 |
| Free cash flows | 626 | (431) |
all amounts in millions of euros unless otherwise stated
| 2012 | 2013 | |||||||
|---|---|---|---|---|---|---|---|---|
| 1st quarter | 2nd quarter | 3rd quarter | 4th quarter | 1st quarter | 2nd quarter | 3rd quarter | 4th quarter | |
| Sales | 5,307 | 5,570 | 5,821 | 6,759 | 5,258 | |||
| % increase | 8 | 15 | 16 | 9 | (1) | |||
| EBITA | 451 | 339 | 366 | (50) | 402 | |||
| as a % of sales | 8.5 | 6.1 | 6.3 | (0.7) | 7.6 | |||
| EBIT | 341 | 229 | 254 | (176) | 305 | |||
| as a % of sales | 6.4 | 4.1 | 4.4 | (2.6) | 5.8 | |||
| Net income (loss) | 183 | 102 | 105 | (420) | 162 | |||
| Net income (loss) - shareholders per | ||||||||
| common share in euros - basic | 0.20 | 0.11 | 0.11 | (0.46) | 0.18 | |||
| January | January | January | January | January | January | January | January | |
| March | June | September | December | March | June | September | December | |
| Sales | 5,307 | 10,877 | 16,698 | 23,457 | 5,258 | |||
| % increase | 8 | 11 | 13 | 12 | (1) | |||
| EBITA | 451 | 790 | 1,156 | 1,106 | 402 | |||
| as a % of sales | 8.5 | 7.3 | 6.9 | 4.7 | 7.6 | |||
| EBIT | 341 | 570 | 824 | 648 | 305 | |||
| as a % of sales | 6.4 | 5.2 | 4.9 | 2.8 | 5.8 | |||
| Net income (loss) | 183 | 285 | 390 | (30) | 162 | |||
| Net income (loss) - shareholders per common share in euros - basic |
0.20 | 0.31 | 0.42 | (0.04) | 0.18 | |||
| Net income (loss) from continuing | ||||||||
| operations as a % of shareholders' equity | 6.3 | 4.3 | 4.0 | (0.6) | 5.8 | |||
| period ended 2012 | period ended 2013 | |||||||
| Inventories as a % of sales1) | 16.9 | 17.2 | 16.9 | 14.3 | 15.5 | |||
| Inventories excluding discontinued operations |
3,623 | 3,812 | 3,877 | 3,359 | 3,629 | |||
| Net debt : group equity ratio | 6:94 | 13:87 | 11:89 | 6:94 | 12:88 | |||
| Total employees (in thousands) | 122 | 122 | 121 | 118 | 118 | |||
| of which discontinued operations | 2 | 2 | 2 | 2 | 2 |
1) Excludes discontinued operations for both inventories and sales figures
Information also available on Internet, address: www.philips.com/investorrelations
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.